← Leaderboards
Menashe Bareli
University Of Texas Md Anderson Can Ctr
$6,643,202
Attributed
$6,643,202
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $730.8K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,643,202 · 7
By mechanism
R01$3,694,893 · 2
P50$2,570,730 · 4
R21$377,579 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- William Francis Benedict$3,785,293
- Rakesh Kumar$9,172,951
- Colin P Dinney$4,248,660
- David J McConkey$4,498,182
- John L Clifford$553,681
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaPhenotypeBaseNeoplasm MetastasisIn VivoIl8 GeneTumor GrowthUp-Regulation (Physiology)MolecularLaboratoriesSuccessGenesModalityNeoplastic CellMelanoma CellMetastatic MelanomaCellsThrombin ReceptorGrowthTranscription FactorTumorCutaneous MelanomaAngiogenesisPre-Clinical
Grant awards (33)
A-to-I microRNA Editing and Melanoma Metastasis$168,779
R21 · FY2019 · CA · contact PI
A-to-I microRNA Editing and Melanoma Metastasis$208,800
R21 · FY2018 · CA · contact PI
Targeting Angiogenesis and the Tumor Microenvironment Utilizing si RNA$122,475
P50 · FY2014 · CA · contact PI
AKT-Vimentin interaction; a potential role in soft tissue sarcoma progression and$291,366
R01 · FY2013 · CA · contact PI
Targeting Angiogenesis and the Tumor Microenvironment Utilizing si RNA$215,054
P50 · FY2013 · CA · contact PI
AKT-Vimentin interaction; a potential role in soft tissue sarcoma progression and$309,964
R01 · FY2012 · CA · contact PI
Malignant melanoma: Regulation by AP-2 and PAR-1$262,932
R01 · FY2012 · CA · contact PI
Targeting Angiogenesis and the Tumor Microenvironment Utilizing si RNA$157,950
P50 · FY2012 · CA · contact PI
Malignant melanoma: Regulation by AP-2 and PAR-1$262,932
R01 · FY2011 · CA · contact PI
Targeting Angiogenesis and the Tumor Microenvironment Utilizing si RNA$130,705
P50 · FY2011 · CA · contact PI
Biology and Therapeutic Targeting of the Epidermal Growth Factor Receptor in Blad$286,076
P50 · FY2010 · CA · contact PI
Malignant melanoma: Regulation by AP-2 and PAR-1$271,063
R01 · FY2010 · CA · contact PI
Targeting Angiogenesis and the Tumor Microenvironment Utilizing si RNA$138,569
P50 · FY2010 · CA · contact PI
Biology and Therapeutic Targeting of the Epidermal Growth Factor Receptor in Blad$288,948
P50 · FY2009 · CA · contact PI
Malignant melanoma: Regulation by AP-2 and PAR-1$271,063
R01 · FY2009 · CA · contact PI
Malignant melanoma: Regulation by AP-2 and PAR-1$271,063
R01 · FY2008 · CA · contact PI
Biology and Therapeutic Targeting of IL-8 and MUC18/MCAM in Melanoma$236,663
P50 · FY2008 · CA · contact PI
Biology and Therapeutic Targeting of the Epidermal Growth Factor Receptor in Blad$222,517
P50 · FY2008 · CA · contact PI
Biology and Therapeutic Targeting of IL-8 and MUC18/MCAM in Melanoma$243,416
P50 · FY2007 · CA · contact PI
Malignant Melanoma: Regulation by AP-2 and PAR-2$258,041
R01 · FY2006 · CA · contact PI
BIOLOGY AND THERAPEUTIC TARGETING OF IL-8 AND MUC18/MCAM$176,119
P50 · FY2006 · CA · contact PI
Malignant Melanoma: Regulation by AP-2 and PAR-2$264,250
R01 · FY2005 · CA
BIOLOGY AND THERAPEUTIC TARGETING OF IL-8 AND MUC18/MCAM$176,119
P50 · FY2005 · CA
Malignant Melanoma: Regulation by AP-2 and PAR-2$264,250
R01 · FY2004 · CA
BIOLOGY AND THERAPEUTIC TARGETING OF IL-8 AND MUC18/MCAM$176,119
P50 · FY2004 · CA
Malignant Melanoma: Regulation by AP-2 and PAR-2$264,250
R01 · FY2003 · CA
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA$218,370
R01 · FY2002 · CA
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA$43,500
R01 · FY2002 · CA
EPIDERMAL GROWTH FACTOR RECEPTOR IN BLADDER CANCER$0
P50 · FY2002 · CA
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA$212,012
R01 · FY2001 · CA
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA$24,000
R01 · FY2001 · CA
EPIDERMAL GROWTH FACTOR RECEPTOR IN BLADDER CANCER$0
P50 · FY2001 · CA
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA$205,837
R01 · FY2000 · CA